FDA Inspection 1013834 — Department Of Defense - Army

Department Of Defense - Army — FEI 1000523903

The FDA completed an inspection of Department Of Defense - Army on May 18, 2017 in Tacoma, WA. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Biologics.

Inspection details

Classification
No Action Indicated (NAI)
End Date
May 18, 2017
Fiscal Year
2017
Product Type
Biologics
Project Area
Blood and Blood Products
Location
Tacoma, WA (United States)

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.